SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA

Completed · Phase 4

Conditions studied: Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasm

In brief

The goal of this interventional clinical trial is to evaluate the dose of radiation of Technetium-99m macroaggregated-albumin (99mTc-MAA) after an intra-arterial injection to the whole body and non-liver critical organs in patients who are undergoing evaluation for SIR-Spheres treatment for hepatocellular carcinoma.

Key facts

Study ID

NCT05848947

Run by

Sirtex Medical

People needed

5

Starts

2023-04-25

Expected to finish

2023-07-05

Last updated by the study team

2025-01-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Willing, able, and mentally competent to provide written informed consent
• Age 18 or older at the time of consent
• Patients who are being evaluated for SIR-Spheres treatment eligibility

You may not qualify if…

• Patients who are contraindicated for SIR-Spheres treatment
• Patients who are contraindicated for 99mTc-MAA per the manufacturer's package insert

Where it is running

• Inland Imaging — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.